AYTU BIOPHARMA, INC Lessee, Operating Lease, Liability, Undiscounted Excess Amount
AYTU BIOPHARMA, INC (AYTU) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $253.00 thousand as of 2026-06-30, per its 10-K filed 2026-09-22.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-09-22
- 2026-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $253.00K.
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $285.00K.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $317.00K.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $351.00K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-06-30 | $253.00K 10-K · filed 2026-09-22 |
| 2026-03-31 | $285.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $317.00K 10-Q · filed 2026-02-03 |
| 2025-09-30 | $351.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $386.00K 10-K · filed 2025-09-23 |
| 2025-03-31 | $421.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $479.00K 10-Q · filed 2025-02-12 |
| 2024-09-30 | $520.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $555.00K 10-K · filed 2024-09-26 |
| 2024-03-31 | $286.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $332.00K 10-Q · filed 2024-02-14 |
| 2023-09-30 | $389.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $173.00K 10-K · filed 2023-10-12 |
| 2023-03-31 | $218.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $268.00K 10-Q · filed 2023-02-21 |
| 2022-09-30 | $323.00K 10-Q/A · filed 2023-02-21 |
| 2022-06-30 | $382.00K 10-K · filed 2022-09-27 |
| 2022-03-31 | $448.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $519.00K 10-Q · filed 2022-02-14 |
| 2021-09-30 | $445.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $445.00K 10-K · filed 2021-09-28 |
| 2021-03-31 | $508.00K 10-Q · filed 2021-05-17 |
| 2020-09-30 | $45.05K 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |